Atria Investments’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Buy |
22,087
+4,574
| +26% | +$98.7K | 0.01% | 1450 |
|
|
2025
Q1 | $291K | Buy |
17,513
+4,111
| +31% | +$68.3K | ﹤0.01% | 1632 |
|
|
2024
Q4 | $246K | Sell |
13,402
-11,035
| -45% | -$202K | ﹤0.01% | 1694 |
|
|
2024
Q3 | $376K | Buy |
24,437
+2,384
| +11% | +$36.7K | ﹤0.01% | 1483 |
|
|
2024
Q2 | $358K | Buy |
+22,053
| New | +$358K | ﹤0.01% | 1482 |
|